Michael G. Schlossmacher

Amyloid β-peptide is produced by cultured cells during normal metabolism

Christian Haass, Michael G. Schlossmacher, Albert Y. Hung et al. · Nature · 1992 · 1.9K citations

Amyloid β-Peptide, Protein Expression, Biochemistry +11

Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease

John P. Anderson, Donald E. Walker, Jason Goldstein et al. · Journal of Biological Chemistry · 2006 · 1.4K citations · Full text

Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease

Hideki Shimura, Michael G. Schlossmacher, Nobutaka Hattori et al. · Science · 2001 · 1K citations

Dopamine covalently modifies and functionally inactivates parkin

Matthew J. LaVoie, Beth L. Ostaszewski, Andreas Weihofen et al. · Nature Medicine · 2005 · 712 citations

Functional Selectivity, Medicine, Neurotransmitter +5

Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease

Omar M. A. El‐Agnaf, Sultan A. Salem, Katerina E. Paleologou et al. · The FASEB Journal · 2006 · 700 citations

Pathology, Soluble Aggregates, Neurochemical Biomarkers +19